N. Péquériaux

发表

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients

F. Dekker, P. Blankestijn, G. Ocak, 2021, BMC Nephrology.

Impact of COVID‐19 pandemic on the quality of test output in haemostasis laboratories

M. D. de Maat, P. Meijer, M. J. Hollestelle, 2021, International journal of laboratory hematology.

Effects of time and temperature on 48 routine chemistry, haematology and coagulation analytes in whole blood samples

R. Kusters, E. Gemen, N. Péquériaux, 2017, Annals of clinical biochemistry.

Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.

F. Dekker, R. Krediet, J. Beutler, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Perioperative bridging of anticoagulation: towards a more reserved approach.

H. Büller, N. Péquériaux, M. Coppens, 2019, The Netherlands journal of medicine.

Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements

N. Péquériaux, A. Van den Besselaar, J. H. V. van Geest-Daalderop, 2009, Thrombosis and Haemostasis.

Investigating unexpected INRs: in search of the culprit--adherence, interactions, genetics, and superwarfarin.

P. Schmeits, M. Hermans, J. Conemans, 2009, The Netherlands journal of medicine.

Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model

M. Levi, B. Hutten, N. Péquériaux, 2009, Journal of Thrombosis and Thrombolysis.

Invasive procedures in the outpatient setting: Managing the short-acting acenocoumarol and the long-acting phenprocoumon

M. Levi, B. Hutten, N. Péquériaux, 2007, Thrombosis and Haemostasis.

The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: Consequences for the assessment of the dose

M. Levi, B. Hutten, N. Péquériaux, 2007, Thrombosis and Haemostasis.

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

F. Leebeek, A. V. van Gammeren, M. D. de Maat, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Age of platelet concentrates and time to the next transfusion

H. Putter, F. Weerkamp, O. Visser, 2018, Transfusion.

Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

O. Visser, J. Zwaginga, J. G. van der Bom, 2016, The Lancet. Haematology.

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans

O. Visser, J. Zwaginga, J. G. van der Bom, 2017, Haematologica.

Haloperidol Does Not Activate Thrombogenic Factors in Older, Nonpsychotic Hospitalized Patients

R. V. van Marum, P. Nanayakkara, N. Péquériaux, 2017, Journal of clinical psychopharmacology.

Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients

O. Visser, J. Zwaginga, J. G. van der Bom, 2017, JAMA.

Red cell alloimmunisation in patients with different types of infections

O. Visser, J. Zwaginga, J. G. van der Bom, 2016, British journal of haematology.

Analytical Performance of a Direct Assay for LDL-Cholesterol

Eva M. L. Smets, V. Blaton, N. Péquériaux, 2001, Clinical chemistry and laboratory medicine.

The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation

J. Zwaginga, Nel Som, J. G. van der Bom, 2021, British journal of haematology.

Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization

O. Visser, J. Zwaginga, J. G. van der Bom, 2017, Haematologica.

Point-of-care monitoring of vitamin K-antagonists: validation of CoaguChek XS test strips with International Standard thromboplastin

F. V. D. van der Meer, N. Péquériaux, A. Van den Besselaar, 2012, Journal of Clinical Pathology.

Adapt and adopt ? The non-evidence based implementation 273 of evidence-based guidelines

H. Büller, N. Péquériaux, M. Coppens, 2019 .

Multicentre evaluation of the EBIO plus glucose analyser.

H. Adriaansen, R. N. Idema, N. Péquériaux, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient.

M. Blankenstein, N. Péquériaux, H. L. V. van Duijnhoven, 1996, Clinical chemistry.

Association between renal failure and red blood cell alloimmunization among newly transfused patients

O. Visser, J. Zwaginga, J. G. van der Bom, 2020, Transfusion.